ARCHIVES

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

This article is from The Cancer Letter archive.

Vol. 15 No. 37 | September 29, 1989

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996